Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | KCNJ1 | P48048 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | HTR6 | P50406 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | CCR3 | P51677 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3029327 | 0.93 | MMP2 (0.34) | LMNAALDH1A1KMT2AGAAKDM4E | |
| SCHEMBL3797892 | 0.91 | ALDH1A1 (0.36) | LMNAALDH1A1KMT2AGAAKCNJ1 | |
| SCHEMBL3022412 | 0.90 | TDP2 (0.35) | LMNAALDH1A1KMT2AGAAMEN1 | |
| SCHEMBL3017584 | 0.88 | TXNRD1 (0.33) | LMNAALDH1A1KMT2AKCNJ1KCNH2 | |
| SCHEMBL3802083 | 0.88 | XDH (0.35) | LMNAALDH1A1KMT2AKDM4EMAPT | |
| SCHEMBL3793891 | 0.87 | LMNA (0.37) | LMNAALDH1A1KMT2AHTR6KDM4E | |
| SCHEMBL3027934 | 0.86 | ALDH1A1 (0.41) | LMNAALDH1A1KMT2AKDM4EMAPT | |
| SCHEMBL3022044 | 0.83 | LMNA (0.35) | LMNAALDH1A1KMT2AGAAKCNJ1 | |
| SCHEMBL3031270 | 0.82 | MMP2 (0.33) | LMNAALDH1A1KMT2AGAAHTR6 | |
| SCHEMBL3017368 | 0.82 | AR (0.33) | ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100190794-A1 | Herbicidally Active Composition | BASF SE (DE) | 2010-07-29 | — | — | US | claimed |
| US-20100173777-A1 | Piperazine Compounds Having Herbicidal Action | BASF SE (DE) | 2010-07-08 | — | — | US | claimed |
| EP-2157856-A1 | HERBICIDALLY EFFECTIVE COMPOSITION | Basf Se (DE) | 2010-03-03 | — | — | EP | claimed |
| EP-2054394-B1 | PIPERAZINE COMPOUNDS WITH A HERBICIDAL ACTION | BASF SE (DE) | 2009-11-18 | — | — | EP | claimed |
| EP-2054394-A2 | PIPERAZINE COMPOUNDS WITH A HERBICIDAL ACTION | Basf Se (DE) | 2009-05-06 | — | — | EP | claimed |
| WO-2008152074-A1 | HERBICIDALLY EFFECTIVE COMPOSITION | BASF SE (DE) | 2008-12-18 | — | — | WO | claimed |
| WO-2008152072-A2 | PIPERAZINE COMPOUNDS WITH A HERBICIDAL ACTION | BASF SE (DE) | 2008-12-18 | — | — | WO | claimed |
| US-20100190794-A1 | Herbicidally Active Composition | BASF SE (DE) | 2010-07-29 | — | — | US | disclosed |
| US-20100173777-A1 | Piperazine Compounds Having Herbicidal Action | BASF SE (DE) | 2010-07-08 | — | — | US | disclosed |
| EP-2157856-A1 | HERBICIDALLY EFFECTIVE COMPOSITION | Basf Se (DE) | 2010-03-03 | — | — | EP | disclosed |
| EP-2054394-B1 | PIPERAZINE COMPOUNDS WITH A HERBICIDAL ACTION | BASF SE (DE) | 2009-11-18 | — | — | EP | disclosed |
| EP-2054394-A2 | PIPERAZINE COMPOUNDS WITH A HERBICIDAL ACTION | Basf Se (DE) | 2009-05-06 | — | — | EP | disclosed |
| WO-2008152074-A1 | HERBICIDALLY EFFECTIVE COMPOSITION | BASF SE (DE) | 2008-12-18 | — | — | WO | disclosed |
| WO-2008152072-A2 | PIPERAZINE COMPOUNDS WITH A HERBICIDAL ACTION | BASF SE (DE) | 2008-12-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100190794-A1 | Herbicidally Active Composition | ECI1, ACLY, SQOR | LMNA 3263/4885ALDH1A1 1128/4885KMT2A 2213/4885 |
| US-20100173777-A1 | Piperazine Compounds Having Herbicidal Action | CBR3, CBR1, CNPY2 | LMNA 1108/4885ALDH1A1 1174/4885KMT2A 3366/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.